Lessina Kit
Product Images NDC 0555-9014
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lessina (NDC 0555-9014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Mean Levonorgestrel and Ethin Estradiol Concentrations were tested in serum after a single dose and on day 21 of cycles 1 and 3. The graph shows the results of the tests conducted for levonorgestrel where the concentration was 5000 at a single dose and decreased gradually over time, and the concentrations for ethin estradiol were tested at a single dose and on day 21 of cycles 1 and 3. The graph depicts the ethin estradiol concentrations decreasing gradually over time.*
Image 4
Image 5
This is a label or instruction for storing medication named "Lejjma" which contains two active ingredients, levonorgestrel, and ethinyl estradiol. The medication should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and should be kept at the US Pharmacopeia controlled room temperature.*
Image 6
Image 7
This is a description of a medication in blister card packaging. The medication is a combination of levonorgestrel and ethinyl estradiol tablets, intended for the prevention of pregnancy. The tablets have a strength of 0.1mg/0.02mg. The product does not provide protection against HIV or other sexually transmitted diseases. The manufacturer is Teva Pharmaceuticals, based in North Wales, PA.*
Image 8
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.